Document is current
Any future updates will be listed below
-
Authors
Tohi, Yoichiro https://orcid.org/0000-0003-3884-8915
Kato, Takuma
Fukuhara, Hideo
Kobayashi, Keita
Ohira, Shin
Ikeda, Kenichiro
Daizumoto, Kei
Katayama, Satoshi
Shimizu, Ryutaro
Nishimura, Kenichi
Nagami, Taichi
Hayashida, Yushi
Hirama, Hiromi
Takamoto, Atsushi
Dainichi, Teruki
Sugimoto, Mikio
,
Inoue, Keiji
Yamamoto, Shinkuro
Matsuyama, Hideyasu
Nagai, Atsushi
Hinata, Nobuyuki
Kanayama, Hiroomi
Nasu, Yasutomo
Takenaka, Atsushi
Saika, Takashi
Wada, Koichiro
Tohi, Yoichiro https://orcid.org/0000-0003-3884-8915
Kato, Takuma
Fukuhara, Hideo
Kobayashi, Keita
Ohira, Shin
Ikeda, Kenichiro
Daizumoto, Kei
Katayama, Satoshi
Shimizu, Ryutaro
Nishimura, Kenichi
Nagami, Taichi
Takamoto, Atsushi
Sugimoto, Mikio
- License Information
-
More Information
Article History
Received: 29 March 2022
Accepted: 25 April 2022
First Online: 20 May 2022
Declarations
:
: MS received honoraria from Janssen Pharmaceutical K.K.
: This study was approved by the Institutional Review Board of Kagawa University (admission number: 2021-050). All procedures were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and the principles of the 1964 Helsinki Declaration and its later amendments. The need for informed consent was waived given the retrospective nature of the study; however, information on this study was disclosed on the website, where patients were offered the opportunity to refuse inclusion in this study.
